Navigation Links
Dragon Pharma announces 2007 full year financial results
Date:3/31/2008

2006. Mainly driven by the rising customer demand in the Indian market, sales revenue from Clavulanic Acid also increased by 49% to $16.8 million while total sales quantity increased 63% to 39 tons, up from 24 tons in 2006. As a result of the increased sales, combined with higher facility utilization and improved production technology, the Chemical Division's gross margin for 2007 increased to 28.13% from 19.86% for 2006.

The Company views its research and development capability as a competitive edge and constantly strives to improve its production technology so as to enhance core capability. An important achievement that was completed in 2007 was the successful adoption of an enzymatic process to the production of 7-ACA. Currently the Company is in the process of converting its entire production to incorporate this innovative technology. It is expected that the overall adoption will further lower the production costs and additionally reduce the amount of capital investment pertaining to the environment protection. In addition, subsequent to the year end of 2007, the Company has increased its annual production capacity for 7-ACA and Clavulanic Acid by 30% and 56% respectively in order to meet rising customer demand. Management believes that all these improvements will further reinforce its market leadership position and contribute positively to its financial performance in the coming years.

With a more focused antibiotic product portfolio and effective marketing strategies, the Company has also substantially increased its sales and improved its gross margin for the formulation drugs. By strengthening its sales team and utilizing its national distribution network and close customer relationship, the Company has significantly expanded its market share in the Chinese market. Mainly due to the increased sales volume and selling prices, revenues for the Pharma Division have climbed to $16.9 million in 2007, up 156% from $6.6 million in 2006, and the gross
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Dragon retains leading investor relations firm
2. Dragon announces new product launch; increase in annual production output capacity
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Transgenomic Opens Pharmacogenomics Laboratory in China
7. PharmAthene Reports Year-End 2007 Financial Results
8. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
9. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
10. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
11. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... EPFL and the University of  Geneva ... John P. Donoghue . The American neuroscientist is ... . The new Wyss Center for Bio- ... Geneva , has named as its director one ... Donoghue , founder of Brown University,s Institute for Brain ...
(Date:7/11/2014)... -- Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/10/2014)... Faso (PRWEB) July 10, 2014 ... today have access to an additional family planning ... access to contraception at all levels of the ... lower-dose formulation of a widely used contraceptive—Pfizer’s Depo-Provera® ... , Burkina Faso is the first of four ...
(Date:7/10/2014)... 10, 2014 Deep Knowledge Ventures ... Forum on ‘Commercialising Longevity Research’ and welcomed a ... the London Bioscience Innovation Center for the event, ... Aging Analytics Ltd. The meeting highlighted the need ... research for age-related disease, as well as the ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6
... MOUNTAINSIDE, N.J., Oct. 16 National Stem,Cell Holding, ... a,provisional patent application for a newly discovered group ... progenitor cell,lines, that may stimulate a variety of ... skins ability to preserve and repair,itself . ...
... Novartis Takes Top Spot, Previously Held by GlaxoSmithKline ... 16 Thomson,Scientific, part of The Thomson Corporation ... of information solutions to the worldwide research and,business ... recent,quarterly review of scientific literature on drugs and ...
... N.Y., Oct. 15 EpiCept Corporation,(Nasdaq and OMX ... Drewe,Senior Director of Lead Discovery, will be presenting ... at the Hotel Del Coronado in San Diego, ... the advances into pre-clinical,testing of drug discovery efforts ...
Cached Biology Technology:National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 2National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 3Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007 2Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007 3EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 2EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 3EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 4EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference 5
(Date:7/11/2014)... 3, 2014, Shenzhen, China Researchers from Salk Institute ... the first time evaluated the safety and reliability ... successfully developed a new method, TALEN-HDAdV, which could ... stem cell (hiPSC). This study published online in ... theoretical foundation for stem cell-based gene therapy. , ...
(Date:7/11/2014)... 11, 2014 The increased risk of kidney injury ... resuscitation fluids reflects the mass of HES molecules, according ... official journal of the International Anesthesia Research Society (IARS). ... harmful effect of HES on cultured human renal proximal ... Christian Wunder and colleagues of University Hospital Wrzburg, Austria. ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the "International Biometrics Technology Market - Industry Analysis ... report to their offering. ... attacks and crimes has created a need for high ... methods used for personnel authentication such as username and ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... Biochemistry demonstrates that grapes are able to reduce heart ... increasing the activity of several genes responsible for antioxidant ... known natural source of antioxidants and other polyphenols, which ... observed with grape consumption. This study, funded by ...
... Brussels-BE, 2 May 2013 -- A new analysis has ... which women with oestrogen-receptor positive breast cancer are at ... and may benefit from prolonged endocrine treatment. The ... with oestrogen-receptor positive breast cancer whose cancer recurs more ...
... A Boston University School of Medicine (BUSM) study ... increase their self-compassion and ability to manage thoughts and ... Education Online , also discusses how this innovative course ... more empowered to use mind-body skills with their patients. ...
Cached Biology News:Study uncovers mechanism for how grapes reduce heart failure associated with hypertension 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 3BUSM study shows positive impact of mind-body course on well-being of medical students 2
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
Request Info...
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
Biology Products: